COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Analyst Coverage

Analyst Coverage

Analyst
Firm
Brandon Folkes
Cantor Fitzgerald
Oren Livnat
HC Wainwright & Co.
Tim Chiang
Northland Securities
David Amsellem
Piper Sandler
Scott Henry
ROTH Capital Partners
Gregg Gilbert
SunTrust Robinson Humphrey, Inc.
Tim Lugo
William Blair

BioDelivery Sciences International, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding BioDelivery Sciences International, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BioDelivery Sciences International, Inc. or its management. BioDelivery Sciences International, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Investor Presentation

More information is coming soon.


Recent BDSI News

BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada September 9, 2021

Expands Portfolio and Establishes Growth Platform in Neurology The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Commercial Launch Planned for Q1 2022 Investor Day on October 14, 2021 RALEIGH, N.C. , Sept. ...

Read more
BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference September 7, 2021

RALEIGH, N.C. , Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will showcase three scientific posters regarding BELBUCA ®  (buprenorphine buccal film), CIII ...

Read more
BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences September 3, 2021

RALEIGH, N.C. , Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey , Chief Executive Officer, and ...

Read more

Upcoming Events

Cantor Fitzgerald Global Healthcare Conference
 Sep 28, 2021 at 9:20 AM EDT
H.C. Wainwright 23rd Annual Global Investment Conference
 Sep 13, 2021 at 7:00 AM EDT

Stay Connected

Stay up to date on the latest news

Get started now
August 28, 2021 /
Data provided by West LLC. Minimum 15 minutes delayed.